OC
HALO icon

Oppenheimer & Co’s Halozyme HALO Stock Holding History

Oppenheimer & Co’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
+15,772
New +$1.08M 0.01% 842
2025
Q4 		– Sell
-11,624
Closed -$853K – 1656
2025
Q3 		$853K Sell
11,624
-3,600
-24% -$239K 0.01% 969
2025
Q2 		$792K Buy
15,224
+5,422
+55% +$309K 0.01% 960
2025
Q1 		$625K Buy
+9,802
New +$569K 0.01% 1002
2023
Q1 		– Sell
-7,899
Closed -$449K – 1413
2022
Q4 		$449K Buy
+7,899
New +$404K 0.01% 945
2022
Q3 		– Sell
-7,544
Closed -$332K – 1408
2022
Q2 		$332K Buy
+7,544
New +$326K 0.01% 1071

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Oppenheimer & Co's HALO Position: Q2 2026 in Review

Oppenheimer & Co opened a new position in Halozyme (HALO) in Q2 2026: 15,772 shares worth $1.23M. The stake represents 0.01% of the portfolio and ranks #842 among its holdings. This is a return to the name: Oppenheimer & Co previously reported a position in HALO as recently as Q3 2025.

Oppenheimer & Co first reported a position in HALO in Q2 2022 and has held it in 6 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Oppenheimer & Co held 15,772 shares of Halozyme worth $1.23M as of Q2 2026.
  • Halozyme was a new Oppenheimer & Co position in Q2 2026.
  • Halozyme made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #842 holding.
  • Oppenheimer & Co first reported a position in Halozyme in Q2 2022 and has held it in 6 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.